Alternate sources and substitutes for therapeutic blood components

R. A. Kahn, R. W. Allen, J. Baldassare

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations

Abstract

With the rapid advancement of technology, blood substitutes and alternate sources of therapeutic blood components are likely to become available, although not for a number of years. Within five to eight years, at least some plasma derivatives probably will be replaced by alternate sources using recombinant DNA technology; substitutes for RBCs and platelets will be much more difficult to develop. Availability of these products will have far-reaching effects on our health care system and it is probably not too soon to anticipate the effects and plan for the consequences.

Original languageEnglish
Pages (from-to)1-12
Number of pages12
JournalBlood
Volume66
Issue number1
DOIs
StatePublished - 1985

Fingerprint Dive into the research topics of 'Alternate sources and substitutes for therapeutic blood components'. Together they form a unique fingerprint.

Cite this